The Energy Code Podcast Por Dr. Mike Belkowski arte de portada

The Energy Code

The Energy Code

De: Dr. Mike Belkowski
Escúchala gratis

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Copyright 2021 All rights reserved. Higiene y Vida Saludable Medicina Alternativa y Complementaria
Episodios
  • Urolithin A & Sleep: The “Mitochondrial Recovery” Angle Nobody’s Studying (Yet)

    Urolithin A & Sleep: The “Mitochondrial Recovery” Angle Nobody’s Studying (Yet)
    Apr 22 2026
    In this Energy Code Deep Dive, Dr. Mike breaks down a mini-review asking a provocative question: could urolithin A support sleep health, indirectly, by improving the biology that makes sleep restorative? The authors don’t claim urolithin A “improves sleep,” and they emphasize a key limitation: there are no direct sleep-outcome studies using EEG, polysomnography, or actigraphy. Instead, they map the pathways that connect urolithin A to sleep-relevant physiology: central circadian clock genes in the SCN, protection against sleep-deprivation–induced neuroinflammation, support for brain mitochondrial integrity and dynamics, and stabilization of the gut microbiota / gut barrier — all systems tightly linked to sleep quality, recovery, and aging. The takeaway isn’t “take urolithin A for sleep.” It’s that the mechanistic groundwork may now be strong enough to justify real sleep trials that measure sleep architecture and circadian markers directly. (Educational content only, not medical advice.) - Article Discussed in Episode: Potential impact of urolithin A on pathways relevant to sleep health: a mini review - Key Quotes From Dr. Mike: “They map out the biological pathways through which urolithin A might influence sleep.” “Urolithin A is not a plant polyphenol in the direct sense. It is a gut microbial metabolite.” “Urolithin A can influence core clock-related genes in the suprachiasmatic nucleus.” “Not because it (urolithin a) is a sedative… but because it may support the deeper biology that makes sleep restorative.” “Sometime in the future — sleep health may not come from forcing the brain to sleep, but from restoring the biology that allows sleep to heal.” - Key Points The paper is hypothesis-building, not a sleep-claims paper. Urolithin A is a gut-derived metabolite from ellagitannins/ellagic acid (pomegranate, berries, nuts). No direct urolithin A sleep studies using EEG / polysomnography / actigraphy were found. Preclinical evidence clusters into 4 domains: SCN clock modulation, sleep-deprivation neuroprotection, mitochondrial integrity, microbiome support. Urolithin A may influence SCN clock genes (e.g., Clock, Cry1, Bmal1) in inflammatory conditions. Sleep deprivation models: urolithin A linked to improved fatigue resistance, lower inflammatory/oxidative markers. Brain resilience: reduced glial activation, lower hippocampal cytokines, preserved mitochondrial morphology/dynamics, better memory task performance post–sleep deprivation. Gut-brain-sleep axis: sleep disruption associates with dysbiosis; urolithin A may help microbiome compositionand barrier function, especially under sleep stress. Serotonin and SIRT1 pathways are more speculative and dose-context dependent. Future direction: controlled trials with objective sleep metrics + circadian markers, and mechanistic studies using physiologic concentrations. - Episode timeline 0:19–1:38 — The premise: a careful question, not a claim (why this paper matters) 1:54–2:53 — What urolithin A is: gut metabolite + why that intersects with sleep systems 2:58–4:32 — Human context + the key limitation: no direct sleep-outcome studies 4:32–5:13 — The “pathway buckets”: clock, brain inflammation, mitochondria, gut microbiota 5:13–6:46 — Circadian angle: SCN genes and rhythm markers (relevance vs proof) 6:46–8:53 — Sleep deprivation models: fatigue, inflammation/oxidative stress, hippocampal protection 8:53–9:55 — The Energy Code frame: restorative sleep depends on mitochondrial + inflammatory resilience 10:03–11:32 — Gut-brain-sleep axis: dysbiosis links + urolithin A as a stabilizer (indirect support) 11:50–13:34 — Speculative pathways: serotonin + SIRT1 as hypothesis generators 14:03–15:20 — What we don’t know + what studies should be done next 15:26–17:04 — Synthesis: sleep support via “restoration biology,” not sedation - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook
    Más Menos
    17 m
  • Why Your Mitochondria Decide If Inflammation Resolves or Turns Chronic

    Why Your Mitochondria Decide If Inflammation Resolves or Turns Chronic
    Apr 20 2026
    In this Energy Code Deep Dive, Dr. Mike breaks down a core idea in modern immunology: immune behavior is metabolically gated — and mitochondria sit at the center of that gate. This review reframes mitochondria as active organizers of immune fate, not just “powerhouses,” showing how mitochondrial fusion/fission balance, ROS tone, mtDNA containment vs leakage, trafficking, mitophagy, and even mitochondria-derived extracellular vesicles (mito-EVs) shape whether immune cells become inflammatory, regulatory, resolving, or stuck in chronic dysfunction. You’ll hear how activation often involves a shift toward glycolysis + anabolic metabolism, while resolution leans back into more stable oxidative metabolism, and how “execution hubs” like mTOR/HIF-1α (pro-inflammatory) and AMPK/SIRT1 (restorative/containment) translate metabolic state into inflammatory output. The episode closes with the translational take: the future isn’t blanket immune suppression — it’s context-aware immunomodulation by targeting mitochondrial architecture, quality control, and metabolic checkpoints. (Educational content only, not medical advice.) - Article Discussed in Episode: Metabolic control of immunity and inflammation: Mitochondrial dynamics, pharmacological targets, and therapeutic opportunities - Key Quotes From Dr. Mike: “The immune system is not just responding to receptors… it is responding through metabolism.” “Metabolism does not just correlate with inflammation, metabolism gates inflammation.” “Mitochondrial integrity becomes the point where upstream immune and metabolic signals are converted into irreversible inflammatory cell death.” “Resolution of inflammation is not only about removing the initial trigger, it is also about reconstituting the mitochondrial architecture that supports homeostasis.” “Immune regulation is not only a matter of what the immune system sees, it is also a matter of what the mitochondria allow.” - Key Points Immune activation isn’t just signaling → it’s metabolic state–dependent, centered on mitochondria. Mitochondria act as decision platforms: ATP, ROS, intermediates, membrane potential, mtDNA integrity. Metabolic inflammatory checkpoints: metabolism doesn’t just correlate with inflammation — it gates it. Activation often shifts toward glycolysis; resolution often favors OXPHOS and resilient mitochondrial networks. mTOR/HIF-1α reinforce glycolysis and inflammatory programming (e.g., IL-1β axis). AMPK/SIRT1 support restraint: homeostasis, antioxidant defense, autophagy/mitophagy, resolution. mtDNA leakage (via pores/VDAC oligomers) can trigger cGAS-STING and inflammasome signaling. Fusion vs fission is a tuning dial: short-term fission can be adaptive; chronic fission can sustain pathology. Mito-EVs can spread mitochondrial state between cells — either supportive or inflammatory, depending on cargo/context. Therapeutic angle: shift immune outcomes by targeting mitochondrial dynamics + MQC, not just cytokines. - Episode timeline 0:19–2:22 — The thesis: immunity is metabolically organized; mitochondria as immune “organizers” 2:24–4:44 — Immunometabolism basics: activation = metabolic rewiring (OXPHOS ↔ glycolysis) 5:34–7:13 — “Metabolic inflammatory checkpoints”: metabolism gates inflammatory permission 7:20–9:47 — Execution hubs: mTOR/HIF-1α vs AMPK/SIRT1 and chronicity vs resolution 10:32–11:30 — Mitoxyperiosis: mitochondrial rupture as a terminal inflammatory death event 11:41–13:49 — Trafficking + spatial immune geometry; mtDNA containment vs escape (cGAS-STING) 13:58–16:10 — ROS nuance + dynamics centerpiece: fission/fusion as intensity and duration control 17:21–19:51 — Mito-EVs: intercellular mitochondrial messaging; QC decisions include export 20:00–22:16 — Pharmacologic opportunities: context-aware immunomodulation via mitochondrial targets 22:23–24:48 — Synthesis: mitochondria “decide” what inflammation becomes - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook
    Más Menos
    25 m
  • Can We “Transplant Mitochondria” to Save Vision? The Case For Vision as an Energy Problem

    Can We “Transplant Mitochondria” to Save Vision? The Case For Vision as an Energy Problem
    Apr 19 2026
    In this Deep Dive, Dr. Mike breaks down a frontier idea in mitochondrial medicine: ocular mitochondrial transplantation — isolating healthy mitochondria and delivering them into specific eye compartments to support bioenergetics in tissues like the retina, retinal pigment epithelium (RPE), and optic nerve head. The promise is obvious: mitochondrial dysfunction shows up across major blinding diseases (AMD, glaucoma/optic neuropathies, diabetic retinopathy), and these tissues are some of the most energy-demanding in the body. But the real focus of this paper is not hype, it’s delivery. The episode walks through what the evidence suggests so far about route-dependent targeting: intravitreal delivery trending toward inner retina/optic nerve head exposure, subretinal delivery aligning with outer retina/RPE exposure, and suprachoroidal delivery looking technically feasible but still biologically unproven for true retinal/RPE uptake. You’ll also hear the key unanswered questions that determine whether this becomes clinical reality: uptake vs signaling effects, persistence/durability, dosing, and immune safety in a tissue with minimal tolerance for inflammation. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondrial Transplantation in the Eye: A Review and Evaluation of Surgical Approaches - Key Quotes From Dr. Mike: “Therapeutic mitochondrial transplantation is, in a sense, taking an existing biological logic and trying to harness it intentionally.” “That means the mitochondria are not some side note in ophthalmology, they are central players.” “You cannot just say put mitochondria into the eye and assume they will reach the right place.” “Intravitrial delivery is probably the most relevant route if your therapeutic target is retinal ganglion cells… or the proximal optic nerve.” “Suprachoroidal delivery appears technically promising, but still biologically uncertain with respect to actual retinal or RPE uptake.” “The concept is biologically plausible, surgically approachable, and anatomically root-dependent.” - Key Points The eye is an extreme bioenergetic environment; mitochondrial failure can map directly onto vision failure. Mitochondrial dysfunction is implicated across AMD, glaucoma/optic neuropathies, diabetic retinopathy, and age-related retinal decline. Horizontal mitochondrial transfer is a real biological phenomenon (TNTs, EVs, free mitochondria), not just theory. Therapeutic effect appears context-dependent: stressed/injured cells may benefit more than “healthy” cells. The central translational problem is delivery + target engagement (getting mitochondria to the right compartment). Intravitreal → mostly inner retina; optic nerve head–directed technique may increase ONH/RNFL exposure. Subretinal → strongest outer retina/RPE exposure but more invasive and less repeat-friendly. Suprachoroidal → technically feasible delivery route; biologic uptake into retina/RPE still uncertain. Mechanism remains unresolved: integration vs paracrine-like signaling vs triggering host repair/mitophagy. Safety is non-negotiable: mitochondria can behave like DAMPs depending on source, purity, mtDNA debris, dose, and repeat exposure. - Episode timeline 0:19–1:15 — The premise: can we deliver healthy mitochondria to the eye clinically? 1:17–2:21 — Why mitochondria matter in vision + the disease landscape (AMD, glaucoma, LHON/DOA, DR) 2:39–4:36 — What “mitochondrial transplantation” means + natural horizontal mitochondrial transfer 4:52–6:59 — Why the eye is uniquely hard: compartments, barriers, and precision targeting 7:24–9:37 — AMD focus: RPE mitochondrial dysfunction + metabolic coupling with photoreceptors 9:37–11:08 — Diabetic retinopathy: mitochondrial oxidative stress + “mitochondrial memory” 11:08–12:28 — Glaucoma/optic neuropathy: RGC energy dependence + early transport bottlenecks 12:28–16:17 — Evidence so far: in vitro uptake; animal intravitreal signals; durability questions 16:22–21:16 — Delivery routes compared: intravitreal vs subretinal vs suprachoroidal (pros/limits) 21:19–23:21 — Safety and immune risk: DAMP biology, purity, source, and repeat dosing concerns 23:25–25:37 — Synthesis: feasibility vs efficacy; “delivery is everything” conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook
    Más Menos
    26 m
Todavía no hay opiniones